期刊文献+

乳腺癌新辅助化疗研究现状 被引量:1

The present status of neoadjuvant chemotherapy on breast cancer
下载PDF
导出
摘要 乳腺癌新辅助化疗日益受到重视 ,与常规辅助化疗相比具有诸多优势 ,现综述近年来新辅助化疗的研究现状和临床应用前景。
出处 《国外医学(肿瘤学分册)》 2003年第6期441-444,共4页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献19

  • 1Chollet P, Amat S, Cure H, et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer[J]. Br J Cancer, 2002, 86(7): 1041-1046.
  • 2Rouzier R, Extra JM, Carton M, et al . Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery[J]. J Clin Oncol, 2001,19 (18): 3828-3835.
  • 3Cance WG, Carey LA, Calvo BF, et al . Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival[J]. Ann Surg, 2002, 236(3):295-302.
  • 4Braud AC, Levy E, Feuilhade F, et al . Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: phase Ⅱ study[J]. AmJ Clin Oncol, 2002, 25(3):303-307.
  • 5Manriac L, Durand M, Avril A, et al . Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre[J]. Ann Oncol, 1991, 2(5):347-354.
  • 6Soloil SM, Pierga JY, Asselain B, et al . Breast tumour response to primary chemotherapy predicts local and distant control as well as survival[J]. Eur J Cancer, 1995, 31A(12) :1969-1975.
  • 7Makris A, Powles TJ, Ashley SE, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast eancer[J]. Ann Oncol, 1998, 9(11): 1179-1184.
  • 8van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902[J]. J Clin Oncol, 2001, 19(22) :4224-4237.
  • 9Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel[J]. J Clin Oncol, 2002, 20(6): 1456-1466.
  • 10Therasse P, Mauriac L, Welnicka Jaskiewicz M, et al. Final results of a randomized phase Ⅲ trial comparing cyclophosphamide,epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study[J]. J Clin Oncol, 2003, 21(5):843-850.

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部